Welcome to our dedicated page for TransDigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TransDigm Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TransDigm Group's regulatory disclosures and financial reporting.
BARR DAVID reported acquisition or exercise transactions in this Form 4 filing.
TransDigm Group director David Barr received 41 shares of Common Stock as a grant. The shares were valued at $1,214.66 per share and were issued on March 20, 2026. After this award, Barr directly owns 32,179 shares. A footnote explains the shares were received in lieu of a semi-annual director fee, based on fair market value under the company’s Director Share Plan.
Graff Michael reported acquisition or exercise transactions in this Form 4 filing.
TransDigm Group director Michael Graff received 30 shares of Common Stock as a stock grant on March 20, 2026. The shares were valued at $1,214.66 per share and were issued in lieu of his semi-annual director fee under the company’s Director Share Plan. Following this grant, he holds 1,683 shares directly, plus additional indirect holdings held by family trusts for the benefit of his children.
Howley W Nicholas reported acquisition or exercise transactions in this Form 4 filing.
TransDigm Group director W. Nicholas Howley received 113 shares of Common Stock as a grant on March 20, 2026. The shares were issued at a fair market value of $1,214.66 per share, in lieu of a semi-annual director fee under the Director Share Plan.
After this award, Howley holds 113 shares directly. He also has indirect beneficial holdings of 8,262 shares through The Howley Family Foundation and 21,547.513 shares through the W. Nicholas Howley Family Trust u/a/d 4/23/99, as reported in this filing.
TransDigm Group director W. Nicholas Howley, through the W. Nicholas Howley Family Trust, reported an option exercise and related share sales. The trust exercised stock options for 10,132 shares of TransDigm common stock at an exercise price of $50.9200 per share, converting them into 10,132 common shares.
The trust then sold 10,132 common shares in multiple open-market transactions on the same date at prices ranging from about $1,205.4151 to $1,231.3415 per share. Following these transactions, the trust continues to hold 21,547.513 TransDigm common shares indirectly attributed to Howley.
TransDigm Group’s Co‑Chief Operating Officer Joel Reiss exercised stock options and then sold shares in the open market. He exercised options for 3,900 shares of common stock at an exercise price of $284.97 per share and acquired the underlying shares.
On the same date, he sold 3,900 common shares in a series of transactions at prices around $1,222.87 to $1,250.65 per share, leaving him with 3,600 common shares held directly. Following the option exercise, he also continues to hold 27,500 stock options scheduled to expire on November 8, 2027. This filing reflects a routine exercise‑and‑sell transaction by a senior executive rather than a change in company operations.
TransDigm Group Incorporated reported the results of its 2026 Annual Meeting of Stockholders. Stockholders elected ten directors, including Jane M. Cronin, Michele L. Santana, and Robert J. Small, with each nominee receiving substantially more votes "for" than "withheld" and with broker non-votes recorded.
Stockholders also ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2026, with 51,593,887 votes for, 1,227,313 against and 12,544 abstentions. In an advisory vote, stockholders approved the compensation of the company’s named executive officers, with 48,583,255 votes for, 1,612,610 against, 20,962 abstentions and 2,616,917 broker non-votes. No other matters were submitted for a vote.
TransDigm Group Inc director Robert J. Small reported an indirect open‑market purchase by Stockbridge Fund, L.P. of 1 share of common stock at $1,285.00 per share on February 25, 2026. The filing notes this purchase was matchable under Section 16(b) with a prior sale of 1 share at $1,335.72 per share by an entity in which he has a pecuniary interest, and he paid the issuer the difference between the two prices. Following the transactions reported, indirect holdings include 366,142 shares held by Stockbridge Fund, L.P., 68,139 shares held by Stockbridge Partners LLC, and 60,246 shares held by certain family trusts, plus 5,625 shares held directly.
TransDigm Group’s Co-Chief Operating Officer Patrick Joseph Murphy exercised stock options and acquired common shares. On February 24, 2026, he exercised options for 1,160 shares and 300 shares of TransDigm common stock.
The 1,160 shares were acquired at $269.42 per share and the 300 shares at $347.17 per share through derivative exercises coded as “M.” Following these transactions, Murphy directly owned 2,515 shares of TransDigm common stock.
TransDigm Group Inc. reported insider activity involving a family trust associated with director W. Nicholas Howley. On February 18, 2026, the W. Nicholas Howley Family Trust u/a/d 4/23/99 sold 10,168 shares of TransDigm common stock in a series of open-market transactions. The weighted-average sale prices ranged from about $1,298.96 to $1,312.24 per share across the reported trades.
On the same date, the trust exercised stock options covering 10,168 shares of common stock at an exercise price of $50.92 per share, with the exercise price adjusted for dividends declared since August 1, 2022. After these transactions, the trust held 30,765.513 shares of common stock and 18,040 stock options indirectly.